Resources

Filter by Category

All Events Webinars Workshops

Filter by Program

Filter by Event Date

C-Path Awarded $1.5 Million Grant from Ara Parseghian Medical Research Fund at Notre Dame to Enhance Collaboration in Niemann-Pick Disease Research

TUCSON, Ariz., August 22, 2024 — Critical Path Institute (C-Path) is thrilled to announce its Critical Path for Lysosomal Diseas

Which New Diagnostics for Tuberculosis, and When?

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

C-Path’s PSTC Releases Points to Consider Outlining Recommendations for Analytical Validation of Assays Used in Qualifying Biomarkers

The document serves as a guide to the analysis of biomarkers in drug development TUCSON, Ariz., June 11, 2019 — The Critical Pat

Drug Repurposing Roadmap that Optimizes Patient Impact through Collaboration

Drug Repurposing for Pandemic Innovation: Establishing an Effective and Efficient Ecosystem

Effective treatments for both existing and emerging diseases may already be available on pharmacy shelves. Many approved drugs...

Mixing Modes of Patient-Reported Outcome Data Collection in Clinical Trials: Recommendations

Evidentiary Considerations

The Duchenne Regulatory Science Consortium – A public-private partnership to facilitate sharing of clinical data for the development of regulatory tools to accelerate drug development (Abstract)

Using Real World Data from CURE ID to Identify Drug Repurposing Opportunities in Mycology: Impact of Climate Change

Previous5657 58...60 Next